We identify MMP9-dependent DPP4 release as a putative biomarker for microglial dysfunction in culture, paving the way for future studies that assess the levels of MMP9 and DPP4 in the biofluids of C9orf72-ALS patients. The gene discussed is DPP4; the disease is amyotrophic lateral sclerosis.